vs

Side-by-side financial comparison of Harmony Biosciences Holdings, Inc. (HRMY) and Rubrik, Inc. (RBRK). Click either name above to swap in a different company.

Rubrik, Inc. is the larger business by last-quarter revenue ($350.2M vs $243.8M, roughly 1.4× Harmony Biosciences Holdings, Inc.). Harmony Biosciences Holdings, Inc. runs the higher net margin — 9.2% vs -18.2%, a 27.5% gap on every dollar of revenue. On growth, Rubrik, Inc. posted the faster year-over-year revenue change (48.3% vs 21.1%). Harmony Biosciences Holdings, Inc. produced more free cash flow last quarter ($126.0M vs $80.7M).

Harmony Biosciences Holdings, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for rare neurological and central nervous system disorders. Its primary market is the United States, with its core product serving patients living with narcolepsy and other sleep-related CNS conditions across adult and pediatric segments.

Rubrik, Inc. is an American cloud data management and data security company based in Palo Alto, California, founded in January 2014. The company is listed on the New York Stock Exchange after going public in April 2024.

HRMY vs RBRK — Head-to-Head

Bigger by revenue
RBRK
RBRK
1.4× larger
RBRK
$350.2M
$243.8M
HRMY
Growing faster (revenue YoY)
RBRK
RBRK
+27.1% gap
RBRK
48.3%
21.1%
HRMY
Higher net margin
HRMY
HRMY
27.5% more per $
HRMY
9.2%
-18.2%
RBRK
More free cash flow
HRMY
HRMY
$45.3M more FCF
HRMY
$126.0M
$80.7M
RBRK

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
HRMY
HRMY
RBRK
RBRK
Revenue
$243.8M
$350.2M
Net Profit
$22.5M
$-63.8M
Gross Margin
71.9%
80.5%
Operating Margin
15.8%
-21.6%
Net Margin
9.2%
-18.2%
Revenue YoY
21.1%
48.3%
Net Profit YoY
-54.6%
51.2%
EPS (diluted)
$0.38
$-0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HRMY
HRMY
RBRK
RBRK
Q4 25
$243.8M
$350.2M
Q3 25
$239.5M
$309.9M
Q2 25
$200.5M
$278.5M
Q1 25
$184.7M
$258.1M
Q4 24
$201.3M
$236.2M
Q3 24
$186.0M
$205.0M
Q2 24
$172.8M
$187.3M
Q1 24
$154.6M
Net Profit
HRMY
HRMY
RBRK
RBRK
Q4 25
$22.5M
$-63.8M
Q3 25
$50.9M
$-95.9M
Q2 25
$39.8M
$-102.1M
Q1 25
$45.6M
$-114.9M
Q4 24
$49.5M
$-130.9M
Q3 24
$46.1M
$-176.9M
Q2 24
$11.6M
$-732.1M
Q1 24
$38.3M
Gross Margin
HRMY
HRMY
RBRK
RBRK
Q4 25
71.9%
80.5%
Q3 25
75.1%
79.5%
Q2 25
81.0%
78.3%
Q1 25
82.7%
77.4%
Q4 24
73.0%
76.2%
Q3 24
77.0%
73.1%
Q2 24
81.4%
48.8%
Q1 24
82.2%
Operating Margin
HRMY
HRMY
RBRK
RBRK
Q4 25
15.8%
-21.6%
Q3 25
27.3%
-30.5%
Q2 25
24.0%
-33.4%
Q1 25
30.4%
-45.0%
Q4 24
27.7%
-52.8%
Q3 24
33.2%
-82.1%
Q2 24
12.4%
-387.0%
Q1 24
33.7%
Net Margin
HRMY
HRMY
RBRK
RBRK
Q4 25
9.2%
-18.2%
Q3 25
21.2%
-31.0%
Q2 25
19.8%
-36.7%
Q1 25
24.7%
-44.5%
Q4 24
24.6%
-55.4%
Q3 24
24.8%
-86.3%
Q2 24
6.7%
-390.8%
Q1 24
24.8%
EPS (diluted)
HRMY
HRMY
RBRK
RBRK
Q4 25
$0.38
$-0.32
Q3 25
$0.87
$-0.49
Q2 25
$0.68
$-0.53
Q1 25
$0.78
$5.69
Q4 24
$0.85
$-0.71
Q3 24
$0.79
$-0.98
Q2 24
$0.20
$-11.48
Q1 24
$0.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HRMY
HRMY
RBRK
RBRK
Cash + ST InvestmentsLiquidity on hand
$775.3M
$307.1M
Total DebtLower is stronger
$163.7M
Stockholders' EquityBook value
$870.2M
$-524.4M
Total Assets
$1.3B
$2.5B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HRMY
HRMY
RBRK
RBRK
Q4 25
$775.3M
$307.1M
Q3 25
$672.6M
$322.7M
Q2 25
$565.3M
$284.0M
Q1 25
$507.0M
$186.3M
Q4 24
$467.2M
$103.9M
Q3 24
$410.5M
$142.3M
Q2 24
$346.9M
$502.6M
Q1 24
$372.4M
Total Debt
HRMY
HRMY
RBRK
RBRK
Q4 25
$163.7M
Q3 25
$168.5M
Q2 25
$172.1M
Q1 25
$175.7M
Q4 24
$179.3M
Q3 24
$182.8M
Q2 24
$186.4M
Q1 24
$190.0M
Stockholders' Equity
HRMY
HRMY
RBRK
RBRK
Q4 25
$870.2M
$-524.4M
Q3 25
$835.1M
$-564.3M
Q2 25
$773.1M
$-556.5M
Q1 25
$720.5M
$-553.7M
Q4 24
$659.2M
$-521.1M
Q3 24
$596.8M
$-499.3M
Q2 24
$538.6M
$-514.6M
Q1 24
$515.4M
Total Assets
HRMY
HRMY
RBRK
RBRK
Q4 25
$1.3B
$2.5B
Q3 25
$1.2B
$2.4B
Q2 25
$1.1B
$1.5B
Q1 25
$1.1B
$1.4B
Q4 24
$999.2M
$1.3B
Q3 24
$928.1M
$1.2B
Q2 24
$858.4M
$1.2B
Q1 24
$847.0M
Debt / Equity
HRMY
HRMY
RBRK
RBRK
Q4 25
0.19×
Q3 25
0.20×
Q2 25
0.22×
Q1 25
0.24×
Q4 24
0.27×
Q3 24
0.31×
Q2 24
0.35×
Q1 24
0.37×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HRMY
HRMY
RBRK
RBRK
Operating Cash FlowLast quarter
$126.2M
$85.5M
Free Cash FlowOCF − Capex
$126.0M
$80.7M
FCF MarginFCF / Revenue
51.7%
23.1%
Capex IntensityCapex / Revenue
0.0%
1.4%
Cash ConversionOCF / Net Profit
5.61×
TTM Free Cash FlowTrailing 4 quarters
$347.9M
$256.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HRMY
HRMY
RBRK
RBRK
Q4 25
$126.2M
$85.5M
Q3 25
$108.7M
$64.7M
Q2 25
$79.3M
$39.7M
Q1 25
$34.0M
$83.6M
Q4 24
$75.6M
$23.1M
Q3 24
$70.5M
$-27.1M
Q2 24
$42.6M
$-31.4M
Q1 24
$31.1M
Free Cash Flow
HRMY
HRMY
RBRK
RBRK
Q4 25
$126.0M
$80.7M
Q3 25
$108.7M
$61.2M
Q2 25
$79.3M
$36.8M
Q1 25
$33.9M
$78.0M
Q4 24
$75.0M
$18.0M
Q3 24
$70.5M
$-29.7M
Q2 24
$42.0M
$-35.0M
Q1 24
$31.1M
FCF Margin
HRMY
HRMY
RBRK
RBRK
Q4 25
51.7%
23.1%
Q3 25
45.4%
19.8%
Q2 25
39.6%
13.2%
Q1 25
18.3%
30.2%
Q4 24
37.3%
7.6%
Q3 24
37.9%
-14.5%
Q2 24
24.3%
-18.7%
Q1 24
20.1%
Capex Intensity
HRMY
HRMY
RBRK
RBRK
Q4 25
0.0%
1.4%
Q3 25
0.0%
1.1%
Q2 25
0.0%
1.0%
Q1 25
0.1%
2.2%
Q4 24
0.3%
2.1%
Q3 24
0.0%
1.3%
Q2 24
0.4%
1.9%
Q1 24
0.0%
Cash Conversion
HRMY
HRMY
RBRK
RBRK
Q4 25
5.61×
Q3 25
2.14×
Q2 25
1.99×
Q1 25
0.75×
Q4 24
1.53×
Q3 24
1.53×
Q2 24
3.68×
Q1 24
0.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HRMY
HRMY

Segment breakdown not available.

RBRK
RBRK

Subscription And Circulation$336.4M96%
Other$12.3M4%
Software And Services$4.9M1%
Maintenance$1.5M0%

Related Comparisons